HIV 1 News and Research

RSS

New findings may help researchers design drugs that can prevent HIV

Researchers at the University of Iowa Carver College of Medicine and University of Nebraska Medical Center have created a three-dimensional picture of an important protein that is involved in how HIV -- the virus responsible for AIDS -- is produced inside human cells. The picture may help researchers design drugs that can prevent HIV from reproducing.

10 Jun 2010

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Roxane Laboratories, Inc. announced today the Abbreviated New Drug Application (ANDA) approval of Valacyclovir Hydrochloride Tablets 500mg and

10 Jun 2010

Global Fund releases mid-year results for HIV, TB, malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.

10 Jun 2010

First clinical trial among African women to test vaginal ring that prevents HIV transmission

The nonprofit International Partnership for Microbicides today announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug that could one day be used to prevent HIV transmission during sex. The clinical trial, known as IPM 015, tests the safety and acceptability of an innovative approach that adapts a successful technology from the reproductive health field to give women around the world a tool to protect themselves from HIV infection.

9 Jun 2010

Faith-based HIV-prevention program for African-American women and girls

Developing and evaluating a faith-based, HIV-prevention program for African-American mothers and their daughters is the focus of Dr. Chisina Kapungu's $795,000 career development grant from the National Institute of Mental Health.

9 Jun 2010

Myriad Pharmaceuticals announces strategic initiatives to focus on oncology pipeline

Myriad Pharmaceuticals, Inc. today announced several strategic initiatives to focus the Company's efforts on its oncology pipeline and to conserve its financial resources to extend the Company's projected cash runway beyond 2013.

9 Jun 2010

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

Today the Global Fund to Fight AIDS, Tuberculosis and Malaria announced its latest prevention and treatment numbers, noting in particular that Global Fund-financed programs have put 2.8 million people on treatment for HIV/AIDS, 7 million people have been treated for tuberculosis and 122 million insecticide-treated nets have been distributed to prevent malaria infection.

9 Jun 2010

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

Bristol-Myers Squibb's plans this month to close its plant in Meymac, France, that manufactures "the last therapeutic option" for HIV-positive babies has drawn criticism from UNITAID, Reuters reports. In an open letter published in the Lancet, UNITAID writes that "[c]losing this factory means that 4,000 to 7,000 babies currently enrolled in treatment plans in developing countries through UNITAID could be left without the medicines they need."

9 Jun 2010

NanoViricides anti-HIV drug candidates demonstrate efficacy in cell culture studies with HIV-1 isolates

NanoViricides, Inc. reports that its anti-HIV drug candidates demonstrated efficacy in the recently completed cell culture studies using two distinctly different HIV-1 isolates. The studies were performed in the laboratory of Carol Lackman-Smith at the Southern Research Institute, Frederick, Maryland.

8 Jun 2010

CMAJ to publish comprehensive new guidelines on immigrant health

CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.

8 Jun 2010

Chemotherapy drug sunitinib promising for HIV-positive cancer patients

Preliminary findings from a unique study with sunitinib suggest that it might be possible to tweak the dosage of chemotherapy drugs used to treat HIV-positive cancer patients to achieve therapeutic benefit. Given the type of drug cocktail patients use to treat their HIV, much more or considerably less chemotherapy may be warranted, say the researchers, part of the NCI-supported AIDS Malignancy Consortium (AMC). The trial design is being presented at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO).

8 Jun 2010

Updated HIV treatment guidelines may benefit individuals infected with HIV: Researchers

Researchers from the BC Centre for Excellence in HIV/AIDS and the University of British Columbia today released a comprehensive study revealing that the 2008 IAS-USA therapy guidelines for commencing HIV treatment would create significant benefits for individuals infected with HIV and society as a whole.

8 Jun 2010

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

Melinda Gates today urged global leaders to make women's and children's health a top priority, and announced that the Gates Foundation will invest $1.5 billion over the next five years to support maternal and child health, family planning, and nutrition programs in developing countries.

8 Jun 2010

HIV & Hepatitis scare after endoscopy at a Warrawong Clinic

The South-Eastern Sydney Illawarra Health Service claims that the risk of contracting blood borne serious viral infections like HIV and Hepatitis are low among patients who had an endoscopy done at a private Warrawong clinic. This clinic came under into the spotlight after investigations started to detect the cause of illness in nine persons who underwent endoscopy. The facility is at Cowper Street, Warrawong run by Dr Zakaria Lakhany and is presently closed.

7 Jun 2010

Cytheris completes €12 million Series D financing

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has completed a €12 million ($15 million) Series D financing.

7 Jun 2010

Elizabeth Glaser Pediatric AIDS Foundation to join with JFC to celebrate Children's Day

The Elizabeth Glaser Pediatric AIDS Foundation will join with Jewelers for Children and other charities on Sunday to celebrate JFC's Children's Day, which commemorates the jewelry industry's charitable efforts on behalf of children throughout the year. This second annual Children's Day concludes with JFC's 12th annual Facets of Hope dinner held in Las Vegas, Nevada, with the theme It's All About the Kids.

5 Jun 2010

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."

5 Jun 2010

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

AIDS Healthcare Foundation (AHF) lauded Gilead Sciences, maker of several key AIDS drugs, for its announcement earlier today that it will offer significant pricing and access concessions for the nation's beleaguered AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need.

5 Jun 2010

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Roche Molecular Diagnostics announced today that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first quantitative viral load test to amplify and detect two separate regions of a target genome and offers a fully automated and reliable solution for physicians to make informed treatment decisions for HIV-1 patients undergoing antiretroviral therapy.

4 Jun 2010

Researchers underscore role of jumping genes in maintaining genetic diversity

Using high-throughput sequencing to map the locations of a common type of jumping gene within a person's entire genome, researchers at the University of Pennsylvania School of Medicine found extensive variation in these locations among the individuals they studied, further underscoring the role of these errant genes in maintaining genetic diversity.

4 Jun 2010

HIV 1 News and Research

New findings may help researchers design drugs that can prevent HIV

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Global Fund releases mid-year results for HIV, TB, malaria

First clinical trial among African women to test vaginal ring that prevents HIV transmission

Faith-based HIV-prevention program for African-American women and girls

Myriad Pharmaceuticals announces strategic initiatives to focus on oncology pipeline

Global Fund to Fight AIDS, Tuberculosis and Malaria demonstrates strong progress in prevention, treatment

UNITAID concerned about infant HIV medication shortage, drug company says supply is sufficient

NanoViricides anti-HIV drug candidates demonstrate efficacy in cell culture studies with HIV-1 isolates

CMAJ to publish comprehensive new guidelines on immigrant health

Chemotherapy drug sunitinib promising for HIV-positive cancer patients

Updated HIV treatment guidelines may benefit individuals infected with HIV: Researchers

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

HIV & Hepatitis scare after endoscopy at a Warrawong Clinic

Cytheris completes €12 million Series D financing

Elizabeth Glaser Pediatric AIDS Foundation to join with JFC to celebrate Children's Day

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

AHF applauds Gilead for offering pricing, access concessions to AIDS Drug Assistance Programs

Roche's new dual-PCR target HIV-1 viral load test receives FDA approval

Researchers underscore role of jumping genes in maintaining genetic diversity

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News